| Q38104712 | Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review |
| Q33718981 | Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens |
| Q36308157 | Efficacy of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis: A Meta-Analysis of Randomized Controlled Trials |
| Q36848826 | Evaluation of clinical and immunological responses: a 2-year follow-up study in children with allergic rhinitis due to house dust mite. |
| Q85944649 | Exhaled nitric oxide measures allergy not symptoms in children with allergic rhinitis in primary care: a prospective cross-sectional and longitudinal cohort study |
| Q28082353 | Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials? |
| Q46066121 | Sensitisation patterns and association with age, gender, and clinical symptoms in children with allergic rhinitis in primary care: a cross-sectional study. |
| Q58077091 | Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials |
| Q58700135 | Sublingual allergen immunotherapy for respiratory allergy: a systematic review |
| Q26767010 | Sublingual immunotherapy for pediatric allergic rhinitis: The clinical evidence |
| Q47852864 | Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period |
| Q30440195 | Sublingual immunotherapy: World Allergy Organization position paper 2013 update |